Shares of medical technology company Teleflex (NYSE:TFX) jumped 4.2% in the afternoon session after an activist shareholder ...
Teleflex is selling its acute care, interventional urology, and original equipment manufacturer (OEM) businesses in two separate deals totalling over $2bn as part of the company’s broader portfolio ...
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) announced its financial results for the first quarter of 2025, delivering revenue and earnings that aligned with expectations. While the company faced ...
New, independent, publicly traded company (NewCo) consisting of Teleflex’s Urology, Acute Care, and OEM businesses. RemainCo will consist of Teleflex’s Vascular Access, Interventional, and Surgical ...
Teleflex is a medical device and instrument manufacturer with $3 billion in sales, supplying a wide range of products. The company saw strong growth in the 2010s as growth slowed down in recent years.
• Teleflex (TFX) to host Barrigel™ Educational Symposium featuring a physician panel discussion on the Science of Personalized Spacing with Barrigel™ rectal spacer WAYNE, Pa., Sept. 26, 2024 (GLOBE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results